Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 79 filings·Updated 25 Aug 2026
Showing 10 of 79 filings.
25 Aug 20261 filing
Company UpdateGeneral

Jyothy Labs receives excise duty order for 2016-17; plans appeal, no material impact expected

Excise Duty Order and appeal

  • Date of awareness: August 24, 2026, of an Excise Duty Order under Section 11A(10).
  • Order relates to Apr 2016–Jun 2017 period with duty demand of Rs 9.69 crore.
  • Penalty Rs 0.97 crore and redemption fine Rs 9.69 crore; interest as applicable.
  • Dispute stems from HSN classification interpretation for the product.
  • Previous favorable order at another location; not challenged at higher authorities.
  • Company to file an appeal before appellate authority.
  • No material impact on financials or operations anticipated.
  • Annexure A disclosure attached as per Regulation 30.
Filed 11:27View Source
14 Aug 20261 filing
Company UpdateEarnings Call Transcript

Jyothy Labs Q1 FY27: margins under pressure from crude-linked costs; Exo Liquid and Maxo launches; double-digit growth ex Pril/FA guided

Financial Performance

  • Excluding Pril and FA, revenue grew 8.1% in value terms; 5.3% in volume.
  • Gross margin 38.5%, down 950 bps YoY due to high input costs.
  • EBITDA margin 8.4%, down 820 bps YoY.
  • A&P spend 6.5% of revenue, vs 10.8% in same quarter last year.
  • Net cash balance about INR 850 crores.
  • Fabric Care value growth over 14%, volume growth 10%.
  • Home Care growth 2.4% YoY excluding Pril; Dishwash impacted by Pril exit.
  • Exo Liquid launched; progress encouraging but at early scale-up; end-year visibility.
  • Maxo incense sticks launched in July; priced at parity with competition.
  • Personal Care remains subdued; recovery expected; input costs rising.

Segment Trends & Operating Update

  • Fabric Care continued momentum; value growth >14%, volume growth 10% in Q1.
  • Home Care growth 2.4% YoY excluding Pril; dishwash impacted by Pril exit.
  • Personal Care subdued; expected stronger pickup in coming quarters.
  • Exo portfolio: Exo Liquid scaling up gradually; fuller update by year-end.
  • Maxo expansion: incense sticks launched; competition parity pricing.
  • Channels: Modern Trade & e-commerce among fastest-growing; GT muted due to urban demand.
  • Three-segment reporting introduced: Fabric Care, Home Care, Personal Care; comparatives restated.
  • Pricing strategy: calibrated to balance cost inflation and consumer affordability.
  • A&P reductions; channel investments to support long-term growth.

Balance Sheet and Cash Flow

  • Net cash balance about INR 850 crores.
  • Distributor stock maintained at 15–20 days.
  • Payment terms: hygiene of business maintained; general trade with advanced payments.

Capex & New Products

  • Ind AS 108 alignment; segment reporting revised from Q1 FY27.
  • R&D and cost-optimization investments ongoing; Exo expansion.
  • M&A: looked at assets; four divisions; two not aligned; no forward action yet.

Outlook & Guidance

  • FY27, excluding Pril, double-digit revenue growth expected.
  • H2 should be substantially better than H1; depends on demand momentum and commodity prices.
  • Pricing to remain calibrated; top-line growth to drive margin recovery.

Q&A Highlights

  • Total price increases since the start of the war around 4%–4.5%; 3% in Q1; balance in Q2.
  • Fabric Care price increases closer to 5% portfolio; Dishwash pricing competitive.
  • Working capital hygiene: general trade paid upfront; distributor stock 15–20 days.
  • M&A: exploring assets; filters stringent; not into acquisitions just for growth.
  • Pril cooling-off: Henkel recall; no renewal; court matter; cannot comment beyond this.
  • Double-digit growth aspiration for FY27; ex Pril/FA; high single-digit volume growth; H2 better.
  • Nitin Shakdher: reduce crude dependence; R&D underway.
Filed 18:43View Source
13 Aug 20261 filing
Company UpdateNewspaper Publication

Announcement under Regulation 30 (LODR) - Newspaper Publication

Filed 12:24View Source
12 Aug 20266 filings
Company UpdateAnalyst / Investor Meet

Jyothy Labs conducts virtual analyst/investor conference call on Aug 12, 2026; recording available

Meeting Details

  • Date and time: August 12, 2026 at 16:00 IST.
  • Type: virtual group conference call with analysts/investors.
  • Organizer: Jyothy Labs Limited.
  • Purpose: discuss unaudited quarterly results for quarter ended June 30, 2026 and way forward.

Participants

  • Key participant: Head – Legal & Company Secretary (company representative).

Purpose

  • Purpose: update on unaudited results and forward strategy.

Additional Notes

  • Audio recording of the conference call is available for download.
Filed 18:08View Source
Company UpdateGeneral

Jyothy Labs to transfer Jammu facility leasehold rights to Aikyam Flexipack Private Limited for Rs 9.93 crores

Transaction details

  • Board approved transfer and assignment of Jammu facility leasehold rights to M/s Aikyam Flexipack Private Limited.
  • Jammu facility covers about 15 kanals at SIDCO Industrial Complex, Bari Brahmana, Jammu & Kashmir.
  • Consideration for transfer is Rs 9.93 crores approx.
  • Proposed completion by 31 March 2027, subject to mutual conditions.
Filed 13:52View Source
Company UpdateInvestor Presentation

Jyothy Labs Q1 FY27: Revenue ₹773cr, gross margin 38.5%, PAT ₹47.6cr amid input-cost pressure

Business Overview

  • Core business: Home Care and Personal Care; FY25-26 revenue ₹2,944 cr.
  • Operations: 23 manufacturing plants, 4 million outlets, 1.4 million direct reach, 10,000+ channel partners.
  • New 3-segment structure: Fabric Care, Home Care, Personal Care.
  • Market positioning: rural resilience and value-focused consumer behavior.

Key Operational Highlights

  • Q1 FY27 revenue ₹773 crore; up 3% YoY.
  • Excluding Pril & Fa, value growth 8.1%; volume 5.3%.
  • Gross Margin 38.5% vs 48% prior year.
  • EBITDA margin 8.4% (₹64.7 cr) vs 16.5%.
  • PAT ₹47.6 cr versus ₹96.8 cr.
  • A&P spend ₹50.6 cr (6.5% of revenue), down from ₹58.9 cr.
  • Fabric Care ₹399 cr; Home Care ₹280 cr; Personal Care ₹94 cr.

Financial Performance

  • Revenue growth 3%; gross margin pressure from input inflation.
  • PAT margin 6.2% vs 12.9% prior year.
  • A&P to revenue 6.5% vs 7.8%.

Capital Structure & Liquidity

  • No capital-structure actions disclosed in this update.
  • Shareholding pattern as of 30 June 2026 presented.

Strategic Priorities & Outlook

  • FY27 approach: Defend where we lead; Build where we grow.
  • Margin recovery to be progressive, depending on inflation and geopolitical risks.
  • Scale recent NPDs: Exo Dishwash Liquid, Maxo Incense Sticks.
  • Strengthen salience in Modern Trade, e-commerce, quick commerce.
  • Operational excellence, supply-chain efficiency, and GT productivity.

Risks & Mitigation

  • Gross margin pressured by raw material and packaging inflation.
  • Competitive intensity via price-offs, promotions, and value packs.
  • Demand mix: rural resilience; urban demand subdued.
  • Mitigation: strengthen distribution, value-pack strategies, and cost controls.

Governance & Leadership

  • Shreyas Trivedi serves as Head – Legal & Company Secretary.
Filed 13:38View Source
Company UpdatePress Release / Media Release

Jyothy Labs reports Q1 FY27 revenue ₹773 crore; EBITDA margin 8.4%, up 3% YoY

Financial highlights

  • Revenue ₹773 crore, up 3.0% YoY.
  • Excluding Pril and Fa, revenue up 8.1%, volume up 5.3%.
  • Operating EBITDA ₹64.7 crore, margin 8.4%.
  • Profit After Tax ₹47.6 crore.

Segment performance

  • Fabric Care: 14.1% value growth, 10.2% volume growth.
  • Home Care: 2.4% growth excluding Pril; Exo Dishwash Liquid launched.
  • Maxo Incense Sticks launched in Household Insecticides.

Outlook and strategic actions

  • Margins may improve as inflation moderates; FY27 growth prospects cautiously optimistic.
  • Innovation, premiumisation, and calibrated pricing support long-term growth.
Filed 13:20View Source
Company UpdateInvestor Presentation

Jyothy Labs Q1 FY27 revenue ₹773 cr; margins pressured by input costs amid launches

Business Overview

  • Core business: Home Care and Personal Care with nationwide distribution and 23 manufacturing plants.
  • FY25-26 revenue ₹2,944 crore; 4 million outlets pan-India; 1.4 million direct reach.
  • New three-segment structure: Fabric Care, Home Care, Personal Care.

Financial Performance

  • Q1 FY27 revenue ₹773 crore, up 3% YoY.
  • Gross margin 38.5% vs 48.0% year-ago.
  • Operating EBITDA margin 8.4% (₹64.7 crore) vs 16.5% (₹124.2 crore).
  • PAT ₹47.6 crore vs ₹96.8 crore.
  • Revenue ex-Pril & Fa grew 8.1%; volume +5.3%.
  • A&P expense ₹50.6 crore, 6.5% of revenue, down from ₹58.9 crore.
  • Category mix: Fabric Care +14.1%; Home Care ex-Pril +2.4%; Personal Care +0.4%.

Operational Highlights & Initiatives

  • Exo Dishwash Liquid launched in Rest of India and South.
  • Maxo Agarbatti launched; digital presence strengthened.
  • Margo refreshed with Raashii Khanna; Roz Ki Achhi Aadat campaign.
  • New formats: Exo bio-enzymatic dishwash liquid; Maxo coils expansion.
  • FY27 emphasis on Modern Trade, e-commerce, quick commerce with sharper packs.
  • Operational excellence and supply chain efficiency.
  • Scale NPDs: Exo Dishwash Liquid and Maxo Incense Sticks.

Strategy & Outlook

  • FY27 approach: Defend where we lead; build where we grow.
  • Margin recovery depends on inflation and geopolitical risks.
  • Scale NPDs: Exo Dishwash Liquid and Maxo Incense Sticks.
  • Focus on operational excellence, supply chain efficiency, GT productivity.
  • Sharpen pack-price and channel execution in key growth channels.

Risks

  • Inflation and geopolitical risks could pressure margins.
  • Input cost volatility in raw materials and packaging.
Filed 13:16View Source
ResultFinancial Results

Jyothy Labs Q1 FY27 unaudited results: revenue up modestly, net profit down YoY

Financial Highlights

  • Revenue from operations: ₹77,340 lakhs in Q1 FY27; up from ₹75,121 in Q1 FY26.
  • Total income: ₹79,105 lakhs in Q1 FY27; ₹77,065 in Q1 FY26.
  • Net profit: ₹4,764 lakhs in Q1 FY27; ₹9,679 in Q1 FY26.
  • Basic and diluted EPS: ₹1.30 each.
  • Unaudited results with Limited Review; board approved on Aug 12, 2026.
  • Segment revenue: Fabric Care ₹39,889; Home Care ₹28,019; Personal Care ₹9,432.
  • Segment PBT: Fabric Care ₹3,833; Home Care ₹814; Personal Care ₹1,267.
  • Profit before tax: ₹6,498 lakhs; finance cost ₹120; unallocable exp ₹902; income ₹1,606.
  • Tax expense: ₹1,734; current tax ₹1,252; deferred tax ₹482.
  • Total comprehensive income: ₹4,721 lakhs.
Filed 13:09View Source
31 Jul 20261 filing
Company UpdateGeneral

CRISIL ESG rating 'CRISIL ESG 62' (Strong) assigned to Jyothy Labs for FY2025-26

ESG rating update

  • CRISIL ESG rating 'CRISIL ESG 62' (Strong) assigned to Jyothy Labs for FY2025-26.
  • Jyothy did not engage CRISIL; rating based on public-domain data.
  • Info also disclosed on Jyothy Labs website.
Filed 15:09View Source
Showing 10 of 79 filings